Tevogen bio holdings inc.TVGNW.US Overview
US StockHealthcare
(No presentation for TVGNW)
TVGNW Overall Performance
TVGNW AI Analysis & Strategy
TVGNW Recent Performance
-
Tevogen bio holdings inc.
0.81%
Avg of Sector
-1.14%
S&P500
TVGNW PowerScanner
TVGNW Key Information
TVGNW Valuation Metrics
TVGNW Earnings Table
TVGNW Profile
Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.